T. Rowe Price Investment Management, Inc. Sarepta Therapeutics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,946,240 shares of SRPT stock, worth $243 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,946,240
Previous 1,958,635
0.63%
Holding current value
$243 Million
Previous $309 Million
21.46%
% of portfolio
0.15%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
529Shares Held
84.1MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.12 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$781 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$544 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$533 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.9B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...